Semaglutide weight Loss Injection

Semaglutide Therapy

No Hidden Fees – No Insurance Needed

This service requires a prescription from a CT Weight Loss Shot provider. To get started, please book your consultation.

Starting at

$399 / 3 months

Semaglutide is a compounded version of Ozempic and is one of the most effective weight loss treatments on the market and is considered by many to be the best. It is injected once weekly and used to treat adults who are considered obese or overweight. In a case study that included over 1900 participants, the average adult lost 35 + lbs of their original body weight while taking Semaglutide. This of course depends on the body mass index of the individual.

Semaglutide Benefits include:

If you would like more information regarding this and other weight loss solutions, then please feel free to contact us directly. We can be reached 6 days a week at 475-206-0144 .

Semaglutide injections are FDA-approved GLP-1 agonist medications used to treat obesity and aid in dramatic weight loss. Both once-weekly injections of semaglutide can result in weight loss of more than 50 pounds in as short as six months without requiring a change in food or lifestyle. All health parameters show considerable improvement in overweight individuals who also may have high blood pressure, diabetes, or high cholesterol when used in conjunction with a tailored low-calorie, low-fat diet and activity program to aid in weight loss. Injections of semaglutide belong to the class of drugs known as glucagon-like-peptide-1 (GLP-1) agonists; however, pirzepatide has stronger effects as an insulinotropic polypeptide (GIP) agonist that is dependent on glucose and causes more dramatic weight loss.
A relatively new medication for type 2 diabetes is semaglutide therapy. Semaglutide is an agonist of the glucagon-like peptide 1 receptor (GLP-1 RA) that aids in blood glucose regulation. When blood sugar levels are too high, semaglutide stimulates the pancreas to create insulin; when blood sugar levels are too low, it inhibits the liver’s release of glucose. Additionally slowing down digestion, semaglutide helps individuals with type 2 diabetes absorb meals more gradually and regulate their blood sugar levels. Semaglutide therapy can be taken either on its own or in conjunction with other prescription drugs and changes to one’s diet and exercise routine.

Compared to placebo injections, semaglutide therapy can help enhance beta-cell activity, lower hemoglobin A1c levels, lower body weight, and aid improve glycemic control in persons with type 2 diabetes. A weekly subcutaneous injection of semaglutide at a maximum daily dose of 0.9 milligrams is delivered. Although nausea, vomiting, constipation, diarrhea, and headaches have been linked to semaglutide side effects, they are usually minor and temporary in nature. Since semaglutide also involves the risk of hypoglycemia (low blood sugar), patients on this medicine need to have their blood glucose levels closely monitored.

For those with type 2 diabetes who have not been able to maintain optimal glucose control with current drugs or lifestyle modifications alone, semaglutide therapy can be a useful therapeutic choice overall. Because of its higher efficacy and longer half-life in the body than other GLP-1 RA treatments, semaglutide may offer improved glycemic control. Patients should speak with their healthcare practitioner before beginning semaglutide therapy to make sure it is the right course of treatment for them. Patients must closely monitor their blood glucose levels while taking semaglutide owing to the risk of hypoglycemia.
For those with type 2 diabetes who have not been able to maintain optimal glucose control with current drugs or lifestyle modifications alone, semaglutide therapy can be a useful therapeutic choice overall. Because of its higher efficacy and longer half-life in the body than other GLP-1 RA treatments, semaglutide may offer improved glycemic control. Patients should speak with their healthcare practitioner before beginning semaglutide therapy to make sure it is the right course of treatment for them. Patients must closely monitor their blood glucose levels while taking semaglutide owing to the risk of hypoglycemia.

Tirzepatide vs. Semaglutide: Which Weight Loss Injection is Right for You?

In the quest for effective weight loss, injectable medications have gained immense popularity, with Tirzepatide and Semaglutide leading the charge. Both of these drugs have shown promising results, but they work differently and may be suitable for different individuals. This blog will help you understand the key differences between Tirzepatide and Semaglutide, so you can make an informed decision about which one might be best for your weight loss journey.

What is Tirzepatide?

Tirzepatide is a novel medication that acts as a dual agonist, targeting two key receptors involved in glucose metabolism: the GLP-1 receptor and the GIP receptor. By activating these receptors, Tirzepatide not only helps control blood sugar levels but also promotes weight loss by reducing appetite and increasing feelings of fullness.

What is Semaglutide?

Semaglutide, on the other hand, is a GLP-1 receptor agonist. It mimics the action of the naturally occurring hormone GLP-1, which regulates blood sugar levels, slows gastric emptying, and reduces appetite. Semaglutide has been widely used as a treatment for type 2 diabetes and has gained approval for weight loss in higher doses.

How Do They Compare?

1. Mechanism of Action:

  • Tirzepatide: Dual-action on GLP-1 and GIP receptors.
  • Semaglutide: Single-action on GLP-1 receptor.

2. Efficacy:

  • Tirzepatide: Clinical trials have shown Tirzepatide to result in greater weight loss compared to Semaglutide, with some patients losing up to 22.5% of their body weight.
  • Semaglutide: While effective, Semaglutide generally results in slightly less weight loss compared to Tirzepatide, with an average reduction of around 15% of body weight.

3. Side Effects:

  • Tirzepatide: Common side effects include nausea, vomiting, and diarrhea, particularly when starting the medication.
  • Semaglutide: Similar side effects are seen with Semaglutide, though some users report a higher incidence of gastrointestinal discomfort.

4. Dosing:

  • Tirzepatide: Typically administered once weekly with a gradual increase in dosage.
  • Semaglutide: Also administered once weekly, with a gradual increase in dosage over time.
Shopping Cart